1-2 of 2
Nikolaos Louros
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors

Christine Helsen, Tien T. Nguyen, Xiao Yin Lee, Roy Eerlings, Nikolaos Louros, Joost Schymkowitz, Frederic Rousseau, Frank Claessens, Arnout Voet
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1823–1834.
https://doi.org/10.1158/1535-7163.MCT-22-0340
Published: 02 December 2022
View article titled, Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors
Open the PDF for Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors in another window
Includes: Supplementary data
Journal Articles

Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth

Shauni Lien Geeraerts, Kim Rosalie Kampen, Gianmarco Rinaldi, Purvi Gupta, Mélanie Planque, Nikolaos Louros, Elien Heylen, Kaat De Cremer, Katrijn De Brucker, Stijn Vereecke, Benno Verbelen, Pieter Vermeersch, Joost Schymkowitz, Frederic Rousseau, David Cassiman, Sarah-Maria Fendt, Arnout Voet, Bruno P.A. Cammue, Karin Thevissen, Kim De Keersmaecker
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (1): 50–63.
https://doi.org/10.1158/1535-7163.MCT-20-0480
Published: 05 January 2021
View article titled, Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
Open the PDF for Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth in another window
Includes: Supplementary data